ストックスクリーナーアプリを入手
41.38
1.17%
0.48
プレマーケット:
41.79
0.41
+0.99%
前日終値:
$40.90
開ける：
$41.07
24時間の取引高:
98,689
Relative Volume:
0.88
時価総額：
$610.47M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+8.89%
1か月 パフォーマンス:
-12.77%
6か月 パフォーマンス:
+150.79%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$39.55
$42.20
1週間の範囲:
$38.14
$44.00
52週間の値動き範囲:
$15.00
$53.41
Tectonic Therapeutic Inc Stock (TECX) Company Profile
TECX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
41.38 | 610.47M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-20 | 開始されました | Raymond James | Outperform |
| 2024-08-22 | 開始されました | Wells Fargo | Overweight |
| 2024-06-26 | 開始されました | Piper Sandler | Overweight |
| 2024-06-24 | 開始されました | TD Cowen | Buy |
| 2023-12-18 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-01-05 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-11-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-27 | 開始されました | Needham | Buy |
| 2021-03-09 | 開始されました | Barclays | Overweight |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-11-11 | 開始されました | Berenberg | Buy |
| 2020-03-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 開始されました | Mizuho | Buy |
| 2019-04-05 | 開始されました | Janney | Buy |
| 2018-10-10 | 開始されました | Guggenheim | Buy |
| 2018-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-17 | 開始されました | H.C. Wainwright | Buy |
| 2018-07-16 | 開始されました | Wedbush | Outperform |
| 2018-07-16 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Tectonic Therapeutic Inc (TECX) 最新ニュース
Clarius Group LLC Invests $468,000 in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic Highlights Pipeline and Financial Strength - TipRanks
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $72.25 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 8.8%Should You Sell? - MarketBeat
We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth - Simply Wall St
AVROBIO, Inc. Announces Acceptance of Investigational New Drug Application for Investigator-Sponsored Phase 1/2 Clinical Trial for AVR-RD-04 Gene Therapy for Cystinosis - Marketscreener.com
Tectonic Therapeutic (NASDAQ:TECX) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Sionna Therapeutics Appoints Dr. Marcella Kuhlman Ruddy and Dr. Jo Viney to its Board of Directors - citybiz
FMR LLC's Strategic Acquisition of Tectonic Therapeutic Inc Shar - GuruFocus.com
Geode Capital Management LLC Boosts Stock Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Acquired by Geode Capital Management LLC - MarketBeat
Tectonic Therapeutic: Protein Engineering Platform For GPCRs (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap UpTime to Buy? - MarketBeat
Tectonic Therapeutic: Waiting For A Pullback (NASDAQ:TECX) - Seeking Alpha
Relay Therapeutics (NASDAQ:RLAY) & Tectonic Therapeutic (NASDAQ:TECX) Critical Contrast - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year HighHere's What Happened - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 7.1%Should You Sell? - MarketBeat
Analysts Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $72.25 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 5.5%Time to Buy? - MarketBeat
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $72.25 - MarketBeat
Fmr LLC Grows Position in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Fmr LLC Has $36.97 Million Holdings in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Verition Fund Management LLC Sells 25,902 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Walleye Capital LLC Raises Stock Holdings in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic to Host KOL Event on the Unmet Need in - GlobeNewswire
Acuta Capital Partners LLC Invests $415,000 in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Wells Fargo Initiates Coverage of Tectonic Therapeutic (TECX) with Overweight Recommendation - MSN
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference - GlobeNewswire
Tectonic started at outperform by Raymond James, TX45 cited - MSN
Comparing Cellectis (NASDAQ:CLLS) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic started at outperform by Raymond James, TX45 cited (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Raymond James - MarketBeat
Tectonic Therapeutic initiated with an Outperform at Raymond James - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High Following Analyst Upgrade - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $69.00 - Defense World
Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Reports Q3 2024 Results - Yahoo Finance
BML Capital Management LLC Sells 254,295 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain - Simply Wall St
Tectonic Therapeutic price target raised to $79 from $55 at Wells Fargo - TipRanks
Tectonic Therapeutic Announces Positive Phase 1a Results in - GlobeNewswire
Tectonic's TX45 Shows Strong Phase 1 Results: 42% Renal Flow Boost, 20-Day Half-Life | TECX Stock News - StockTitan
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.38 - Defense World
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $68.50 - Defense World
Tectonic Therapeutic Inc (TECX) 財務データ
Tectonic Therapeutic Inc (TECX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
4.81%
大文字化:
|
ボリューム (24 時間):